title: Psychiatric research: psychoproteomics, degradomics and systems biology.
abstract: While proteomics has excelled in several disciplines in biology (cancer, injury and aging), neuroscience and psychiatryproteomic studies are still in their infancy. Several proteomic studies have been conducted in different areas of psychiatric disorders, including drug abuse (morphine, alcohol and methamphetamine) and other psychiatric disorders (depression, schizophrenia and psychosis). However, the exact cellular and molecular mechanisms underlying these conditions have not been fully investigated. Thus, one of the primary objectives of this review is to discuss psychoproteomic application in the area of psychiatric disorders, with special focus on substance- and drug-abuse research. In addition, we illustrate the potential role of degradomic utility in the area of psychiatric research and its application in establishing and identifying biomarkers relevant to neurotoxicity as a consequence of drug abuse. Finally, we will discuss the emerging role of systems biology and its current use in the field of neuroscience and its integral role in establishing a comprehensive understanding of specific brain disorders and brain function in general.
authors.affiliation: McKnight Brain Institute, Department of Psychiatry, University of Florida College of Medicine, Gainesville, FL 32611, USA. firasko@gmail.com
authors.forename: Firas H
authors.initials: FH
authors.lastname: Kobeissy
authors.forename: Shankar
authors.initials: S
authors.lastname: Sadasivan
authors.forename: Jing
authors.initials: J
authors.lastname: Liu
authors.forename: Mark S
authors.initials: MS
authors.lastname: Gold
authors.forename: Kevin K W
authors.initials: KK
authors.lastname: Wang
mesh_terms: D015415:Biomarkers; D006801:Humans; D001523:Mental Disorders / Q000175:diagnosis / Q000209:etiology; D040901:Proteomics; D011570:Psychiatry / Q000379:methods*; D012106:Research; D049490:Systems Biology
chemical_list: D015415:Biomarkers